A Los Angeles jury has awarded $40 million to two women who claim Johnson & Johnson's talcum powder caused their ovarian cancer.

Texas Attorney General Ken Paxton is accusing the companies behind Tylenol of deceptively marketing the pain reliever to pregnant mothers.

Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business.

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year.

A U.S. bankruptcy court judge has denied Johnson & Johnson’s settlement plan related to baby powder containing talc, providing another setback in the company’s efforts to resolve the matter.

Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years, including four new manufacturing plants.

Johnson & Johnson will spend more than $14 billion to move deeper into treating central nervous system disorders by purchasing Intra-Cellular Therapies.

People with substance use disorder are not getting a direct say on how most opioid settlement money is used.

Medical advocacy groups have welcomed Johnson & Johnson’s decision not to enforce its patent on a critical tuberculosis medication, allowing its production at much lower prices.

A subsidiary of Johnson & Johnson is now proposing paying approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ovarian cancer.

Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.

The Washington state attorney general has announced a $149.5 million settlement agreement with drugmaker Johnson & Johnson, more than four years after the state sued the company over its role in the opioid addiction crisis.

U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug.

Johnson & Johnson is signing off on a new logo, more than 130 years after creating the old one.

Government advisers say the leading decongestant used by millions of Americans to treat nasal congestion doesn't actually work.

Shares are mixed in Asia after the rally on Wall Street fizzled with big declines for Tesla, Netflix and other big tech-oriented stocks.

Johnson & Johnson beat first-quarter expectations, as growth in cancer treatments and the health care giant’s home market helped counter another revenue hit from the strong dollar.

Asian shares are trading mostly lower as investors turn their attention to upcoming earnings reports and other economic indicators.

Johnson & Johnson is earmarking nearly $9 billion to cover allegations that its baby power containing talc caused cancer.

Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue.

Johnson & Johnson is spending about $16.6 billion to buy cardiovascular technology company Abiomed and build up its medical device division.

Asian stock markets are mixed after Wall Street rose on strong corporate profit reports.

Johnson & Johnson topped third-quarter expectations thanks to growth in pharmaceutical sales, but the health care giant continued to tread cautiously with its outlook due to foreign exchange rates.

Johnson & Johnson is pulling baby powder containing talc worldwide next year after it did the same in the U.S. and Canada amid thousands of lawsuits claiming it had caused cancer.

Johnson & Johnson rode growing sales of the cancer treatment Darzalex and other key drugs to a better-than-expected second quarter, but foreign exchange rates again cut into the health care giant’s 2022 forecast.

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths.

A California appeals court has upheld a lower court ruling that Johnson & Johnson must pay $302 million in penalties to the state for deceptively marketing pelvic mesh implants for women.

A trial on whether pharmacy chain Walgreens bears responsibility for the opioid crisis started Monday in Florida on the heels of opening statements last week in another opioid trial in West Virginia.

Lawyers for the state of West Virginia are concluding the first week of a trial against three major opioid makers.

Drugmaker Johnson & Johnson and three major distributors have finalized a nationwide settlement over their role in the opioid addiction crisis.

Money that will flow to Native American tribes as part of an opioid drug settlement with a major manufacturer and three distributors won't come quickly.

Native American tribes have reached opioid settlements worth over a half-billion dollars with drugmaker Johnson & Johnson and three distributors.

The Czech Republic has recorded a significant decline in people dying of COVID-19 despite facing a record number of infected in one month.

Denmark is scraping most pandemic restrictions as the country no longer considers COVID-19 to be “a socially critical disease.”.

Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the health care giant’s COVID-19 vaccine gained momentum as well.

Oregon is on the verge of signing onto a $26 billion settlement with the three largest distributors of opioids and drugmaker Johnson & Johnson after being one of the latest holdout states to join.

U.S. health officials say most Americans should get the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot.

The European Union drugs regulator said Wednesday that people 18 and older can receive a booster shot for the Johnson & Johnson COVID-19 vaccine at least two months after their initial shot of the one-dose vaccine.

The Supreme Court has turned away a request by Johnson & Johnson to halt a Mississippi lawsuit over its talcum power products.

Washington Attorney General Bob Ferguson has taken the state’s case against the nation’s three biggest drug distributors to trial.

Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine from its medical device and prescription drug business.

The Czech government is requiring children to get tested for COVID-19 as part of efforts to curtail a recent steep rise in cases.

Stocks closed broadly higher on Wall Street on Friday, but still marked their first weekly loss in six weeks.

The Oklahoma Supreme Court has overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state’s public nuisance law.

The NBA has told its players, coaches and referees that they should receive booster shots against the coronavirus, with particular urgency for those who received the single-dose Johnson & Johnson vaccine.

Top drug manufacturers have won a round in a California lawsuit that blamed them for the opioid crisis and sought billions of dollars to cover the costs of dealing with it.

A California judge has ruled for top drug manufacturers as local governments seek billions of dollars to cover their costs from the nation’s opioid epidemic.

The Food and Drug Administration is enforcing new warnings on breast implants.

Moderna says its low-dose COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds.

Federal health officials say millions more Americans can get a COVID-19 booster and choose a different vaccine for that next shot.

Asian stock markets are higher after Wall Street rose for a fifth day on strong corporate earnings.

Sales of the cancer treatment Darzalex helped Johnson & Johnson deliver better-than-expected third quarter earnings, while COVID-19 fueled vaccine revenue and had more customers reaching for Tylenol.

Police departments that are requiring officers to be vaccinated against COVID-19 are running up against pockets of resistance across the U.S. Police unions and officers are pushing back by filing lawsuits to block the mandates.

A panel of U.S. health advisers has endorsed booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine.

The Food and Drug Administration is wrestling with how to decide on booster doses of the single-shot Johnson & Johnson COVID-19 vaccine.

COVID-19 test kit maker Ellume is recalling some at-home tests after learning that they were reporting a higher-than-expected rate of false positive results.

Johnson & Johnson has asked U.S. regulators to allow booster shots of its COVID-19 vaccine as the U.S. government moves toward shoring up protection in more vaccinated Americans.

People who got a two-dose vaccine or one dose of the Johnson & Johnson shot are considered fully vaccinated — even without a booster.

Police in Slovenia have fired tear gas and water cannons at thousands of protesters who are against tough anti-coronavirus measures in the small European nation.

Johnson & Johnson says a booster dose to its one-shot coronavirus vaccine provides a strong immune response months after people receive a first dose.

The World Health Organization and its partners hope to provide Africa with about 30% of the COVID-19 vaccines the continent needs by February.

Four companies say they'll move ahead with a $26 billion settlement of lawsuits over the opioid crisis.

Vaccine doses produced by a plant in South Africa will no longer be exported to Europe after the intervention of South Africa’s government, the African Union’s COVID-19 vaccine envoy said Thursday.

Johnson & Johnson says its potential HIV vaccine did not provide protection against the virus in a study of young women in sub-Saharan Africa.

South Africa will this weekend receive 2.2 million Pfizer-BioNTech vaccine doses donated by the United States to add to the 5.6 million doses it received from the U.S. in July.

Pfizer’s COVID-19 vaccine has been given the Food and Drug Administration's full approval, meaning it has now undergone the same rigorous regulatory review as dozens of other established vaccines.

Johnson & Johnson will replace Chairman and CEO Alex Gorsky with another veteran company executive starting next year.

The U.S. is planning booster doses of the Pfizer and Moderna COVID-19 vaccines, but if you got the one-dose Johnson & Johnson shot instead, stay tuned.

Health activists in Africa have slammed Johnson & Johnson for exporting vaccines produced in South Africa to countries in Europe, which have already immunized a large proportion of their populations and often have a surplus of vaccines.

Thousands of new coronavirus cases have been reported in West Africa in recent weeks amid low vaccination rates and the spread of the delta variant.

Millions of people in the U.S. who haven’t gotten the COVID-19 vaccine could soon have a new reason to roll up their sleeves: money in their pockets.

Hundreds of thousands of COVID-19 vaccine doses have been saved from the trash after U.S. regulators extended their expiration date for a second time.

The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine.

Federal health regulators have again extended the expiration dates on Johnson & Johnson’s COVID-19 vaccine by another six weeks.

California and New York City have announced that they will require all government employees to get the coronavirus vaccine or face weekly COVID-19 testing.

South Africa’s acting health minister says the country's COVID-19 vaccination campaign is regaining momentum after being disrupted by a week of riots sparked by the imprisonment of former President Jacob Zuma.

Johnson & Johnson’s second-quarter profit soared 73%, thanks to strong sales growth, particularly in its medical device and diagnostics segment, as hospitals and the health care industry as a whole continue recovering from the coronavirus pandemic.

A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant — but it is far from tying a neat bow on the tangle of still-unresolved lawsuits surrounding the epidemic.

The three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion deal to settle lawsuits brought by state and local governments across the country over the toll of prescription opioids, lawyers suing on behalf of local governments said.

The U.S. will begin making its first COVID-19 vaccine shipments to Africa in the coming days, with the ultimate goal of sharing 25 million doses this summer across the continent in partnership with the African Union.

Johnson & Johnson is recalling five of its sunscreen sprays after discovering low levels of benzene, a chemical that can cause cancer, in some samples.

Johnson & Johnson says it is recalling five of its sunscreen products after some samples were found to contained low levels of benzene, a chemical that can cause cancer with repeated exposure.

Experts around the globe are watching closely to determine if and when people might need another a COVID-19 booster shot.

U.S. regulators added a new warning to Johnson & Johnson’s COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction.

Portugal’s battle to contain the surging COVID-19 delta variant has led it to put the United Kingdom on its red list for travel and cancel school classes in the southern Algarve region, its main tourist attraction.

The New York attorney general says Johnson & Johnson has agreed to pay $230 million to settle claims that the pharmaceutical giant helped fuel the opioid crisis.

From June 15th through the 29th, mobile vaccination clinics are offering free Johnson & Johnson doses because it only requires the one shot.

Johnson & Johnson says U.S. health officials have extended the expiration date for its COVID-19 vaccine by six weeks.

Washington state’s new “joints for jabs” vaccination incentive program is off to a rough start.

Johnson & Johnson is asking for Supreme Court review of a $2 billion verdict in favor of women who claim they developed ovarian cancer from using the company’s talc products.

More cities and states are shrugging off lingering COVID-19 restrictions as vaccination rates rise and the number of infections falls.

The United States and Britain are stepping up calls for the World Health Organization to take a deeper look into the possible origins of COVID-19, including a new visit to China where the first human infections were detected.

COVID-19 killed hundreds of people in one of New York City's most isolated neighborhoods.

Disney’s top executive says the CDC’s decision to ease up mask-wearing requirements for fully vaccinated people is “very big news for us.”.

Medicare says it will require nursing homes to report COVID-19 vaccination rates for residents and staff.

Fewer Americans are reluctant to get a COVID-19 vaccine than just a few months ago, but questions about side effects and how the shots were tested still hold some people back.

Oregon lawmakers have passed a bill to give tenants who are struggling with financial hardships due to the pandemic more time to pay past-due rent.

The Atlanta Braves are providing free COVID-19 vaccinations for fans at Truist Park during their games Friday and Saturday against the Philadelphia Phillies.

Denmark's health authorities say they have removed the single-dose Johnson & Johnson COVID-19 shot from its vaccination program to investigate reports of rare but potentially dangerous blood clots.